Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tristan S Maurer

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Clinical Pharmacology and Therapeutics|January 7, 2021
Nonspecific Binding Considerations in the Rational Design and Development of Small Molecule COVID-19 TherapeuticsTristan S Maurer
Expert Opinion on Drug Discovery|April 9, 2025
Use of pharmacokinetic versus pharmacodynamic endpoints to support human dose predictions: implications for rational drug design and early clinical developmentRui Li, Tristan S Maurer
Biopharmaceutics & Drug Disposition|November 5, 2002
Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discoveryJ Cory Kalvass, Tristan S Maurer
The AAPS Journal|March 20, 2019
Theoretical Considerations for Direct Translation of Unbound Liver-to-Plasma Partition Coefficient from In Vitro to In VivoZhenhong Li, Li Di, Tristan S Maurer
Clinical Pharmacology and Therapeutics|January 17, 2024
Quantitative Model-Based Assessment of Multiple Sickle Cell Disease Therapeutic Approaches Alone and in CombinationAmy T Moody, Jatin Narula, Tristan S Maurer
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 12, 2013
Towards a unified model of passive drug permeation I: origins of the unstirred water layer with applications to ionic permeationAvijit Ghosh, Dennis O Scott, Tristan S Maurer
Journal of Medicinal Chemistry|January 9, 2020
Dose Predictions for Drug DesignTristan S Maurer, Dennis Smith, Kevin Beaumont, et al.
Journal of Medicinal Chemistry|August 5, 2025
Insights on Volume of Distribution of AcidsDennis Smith, Kevin Beaumont, Tristan S Maurer, et al.
Current Drug Metabolism|June 23, 2007
Mechanism-based inactivation of cytochrome P450 enzymes: chemical mechanisms, structure-activity relationships and relationship to clinical drug-drug interactions and idiosyncratic adverse drug reactionsAmit S Kalgutkar, R Scott Obach, Tristan S Maurer
Journal of Medicinal Chemistry|May 7, 2025
Correction to "Dose Predictions for Drug Design"Tristan S Maurer, Dennis Smith, Kevin Beaumont, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Clinical Pharmacology and Therapeutics|January 7, 2021
Nonspecific Binding Considerations in the Rational Design and Development of Small Molecule COVID-19 TherapeuticsTristan S Maurer
Expert Opinion on Drug Discovery|April 9, 2025
Use of pharmacokinetic versus pharmacodynamic endpoints to support human dose predictions: implications for rational drug design and early clinical developmentRui Li, Tristan S Maurer
Biopharmaceutics & Drug Disposition|November 5, 2002
Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discoveryJ Cory Kalvass, Tristan S Maurer
The AAPS Journal|March 20, 2019
Theoretical Considerations for Direct Translation of Unbound Liver-to-Plasma Partition Coefficient from In Vitro to In VivoZhenhong Li, Li Di, Tristan S Maurer
Clinical Pharmacology and Therapeutics|January 17, 2024
Quantitative Model-Based Assessment of Multiple Sickle Cell Disease Therapeutic Approaches Alone and in CombinationAmy T Moody, Jatin Narula, Tristan S Maurer
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 12, 2013
Towards a unified model of passive drug permeation I: origins of the unstirred water layer with applications to ionic permeationAvijit Ghosh, Dennis O Scott, Tristan S Maurer
Journal of Medicinal Chemistry|January 9, 2020
Dose Predictions for Drug DesignTristan S Maurer, Dennis Smith, Kevin Beaumont, et al.
Journal of Medicinal Chemistry|August 5, 2025
Insights on Volume of Distribution of AcidsDennis Smith, Kevin Beaumont, Tristan S Maurer, et al.
Current Drug Metabolism|June 23, 2007
Mechanism-based inactivation of cytochrome P450 enzymes: chemical mechanisms, structure-activity relationships and relationship to clinical drug-drug interactions and idiosyncratic adverse drug reactionsAmit S Kalgutkar, R Scott Obach, Tristan S Maurer
Journal of Medicinal Chemistry|May 7, 2025
Correction to "Dose Predictions for Drug Design"Tristan S Maurer, Dennis Smith, Kevin Beaumont, et al.
Pageof 6